{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:51:39Z","timestamp":1791283899913,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.hoc.2005.07.007","type":"journal-article","created":{"date-parts":[[2005,11,7]],"date-time":"2005-11-07T10:44:29Z","timestamp":1131360269000},"page":"881-896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Pulmonary Hypertension in Sickle Cell Disease: Mechanisms, Diagnosis, and Management"],"prefix":"10.1016","volume":"19","author":[{"given":"Oswaldo","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Gladwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2005.07.007_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/0002-9149(94)90760-9","article-title":"Pulmonary hypertension in sickle cell disease","volume":"74","author":"Sutton","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hoc.2005.07.007_bib2","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0889-8588(05)70401-9","article-title":"Systemic fat embolism and pulmonary hypertension in sickle cell disease","volume":"10","author":"Castro","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.hoc.2005.07.007_bib3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1182\/blood-2002-03-0948","article-title":"Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival","volume":"101","author":"Castro","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.007_bib4","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2141.2005.05432.x","article-title":"Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension","volume":"129","author":"Machado","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.amjmed.2004.03.034","article-title":"Pulmonary hypertension in sickle cell disease","volume":"117","author":"Ataga","year":"2004","journal-title":"Am J Med"},{"issue":"Suppl","key":"10.1016\/j.hoc.2005.07.007_bib7","first-page":"462","article-title":"Pulmonary hypertension in SS, SC and S thalassemia: prevalence, associated clinical syndromes, and mortality [abstract]","volume":"104","author":"De Castro","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.007_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00005792-198801000-00005","article-title":"Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure","volume":"67","author":"Powars","year":"1988","journal-title":"Medicine"},{"key":"10.1016\/j.hoc.2005.07.007_bib9","first-page":"202","article-title":"Sickle cell anemia: \u03b2S-gene-cluster haplotypes as prognostic indicators of vital organ failure","volume":"28","author":"Powars","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2141.1986.tb07560.x","article-title":"Alteration of red cell membrane organization in sickle cell anaemia","volume":"63","author":"Choe","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archinte.1974.00320160118010","article-title":"Hemolysis in sickle-cell disease","volume":"133","author":"Bensinger","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib12","first-page":"17","article-title":"Urinary iron in patients with sickle cell anemia","volume":"86","author":"Washington","year":"1975","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00277-004-0856-9","article-title":"Evidence for a metabolic shift of arginine metabolism in sickle cell disease","volume":"83","author":"Schnog","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/rccm.2304002","article-title":"Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide\/arginine pathway","volume":"168","author":"Jison","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2005.07.007_bib17","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.007_bib18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ana.410200606","article-title":"Sickle cell anemia and central nervous system infarction: a neuropathological study","volume":"20","author":"Rothman","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.hoc.2005.07.007_bib19","first-page":"71","article-title":"Vascular lesions in the central nervous system in sickle cell disease (neuropathology)","volume":"1","author":"Koshy","year":"1990","journal-title":"J Assoc Acad Minor Phys"},{"key":"10.1016\/j.hoc.2005.07.007_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1378\/chest.107.1.50","article-title":"Pulmonary hypertension and right heart failure in patients with \u03b2-thalassemia intermedia","volume":"107","author":"Aessopos","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.hoc.2005.07.007_bib21","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood.V97.11.3411","article-title":"Cardiac involvement in thalassemia intermedia: a multicenter study","volume":"97","author":"Aessopos","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.007_bib22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1183\/09031936.93.04050629","article-title":"Spherocytosis and pulmonary hypertension: coincidental occurrence or causal relationship?","volume":"4","author":"Verresen","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hoc.2005.07.007_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1081\/HEM-120023377","article-title":"An extreme consequence of splenectomy in dehydrated hereditary stomatocytosis: gradual thrombo-embolic pulmonary hypertension and lung-heart transplantation","volume":"27","author":"Jais","year":"2003","journal-title":"Hemoglobin"},{"key":"10.1016\/j.hoc.2005.07.007_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.1107","article-title":"Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency","volume":"67","author":"Chou","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-3476(00)90025-8","article-title":"Congenital dyserythropoietic anemia type I presenting as persistent pulmonary hypertension in the newborn","volume":"136","author":"Shalev","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.hoc.2005.07.007_bib26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1378\/chest.102.2.642","article-title":"Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria","volume":"102","author":"Heller","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.hoc.2005.07.007_bib27","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archinte.1991.00400060133023","article-title":"Primary pulmonary hypertension: its association with microangiopathic hemolytic anemia and thrombocytopenia","volume":"151","author":"Jubelirer","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-0609.2004.00304.x","article-title":"Cardiac status in well-treated patients with thalassemia major","volume":"73","author":"Aessopos","year":"2004","journal-title":"Eur J Hematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension: a national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib30","series-title":"Pulmonary circulation","first-page":"3","article-title":"Pulmonary vascular function","author":"Naeije","year":"2004"},{"key":"10.1016\/j.hoc.2005.07.007_bib31","first-page":"854","article-title":"In vivo study of the sickle cell phenomenon","volume":"56","author":"Jensen","year":"1960","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib32","first-page":"850","article-title":"The in vivo sickle phenomenon: a reappraisal","volume":"81","author":"Serjeant","year":"1973","journal-title":"J Lab Clin Med"},{"issue":"Suppl 1, Part 1","key":"10.1016\/j.hoc.2005.07.007_bib33","first-page":"464","article-title":"Acute on chronic pulmonary hypertension in patients with sickle cell disease [abstract]","volume":"104","author":"Kato","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.007_bib34","unstructured":"Castro O., Kato G., Sachdev V., et al. The sickle cell\u2013pulmonary hypertension screening study: ECHO findings at two-years of follow up [abstract]. Presented at the 27th Annual Meeting of the National Sickle Cell Disease Program. Los Angeles (CA), April 18\u201321, 2004"},{"key":"10.1016\/j.hoc.2005.07.007_bib35","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1378\/chest.108.5.1214","article-title":"The heart in sickle cell anemia: the Cooperative Study of Sickle Cell Disease (CSSCD)","volume":"108","author":"Covitz","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.hoc.2005.07.007_bib36","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/hrt.69.6.536","article-title":"Pulmonary artery pressure and the acute chest syndrome in homozygous sickle cell disease","volume":"69","author":"Denbow","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.hoc.2005.07.007_bib37","unstructured":"Onyekwere O.C., Campbell A., Teshome M., et al. Prevalence of pulmonary hypertension (PHTN) in sickle cell disease (SCD) adolescents with pulmonary complications [abstract]. Presented at the 28th Annual Meeting of the National Sickle Cell Disease Program, Cincinnati, 2005"},{"key":"10.1016\/j.hoc.2005.07.007_bib38","unstructured":"Morris C.R., Gardner J., Hagar W., et al. Pulmonary hypertension in sickle cell disease: a common complication for both adults and children [abstract]. Presented at the 27th Annual Meeting of the National Sickle Cell Disease Program. Los Angeles (CA), April 18\u201321, 2004"},{"key":"10.1016\/j.hoc.2005.07.007_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0066-782X1999001200001","article-title":"Doppler echocardiographic study of adolescents and young adults with sickle cell anemia","volume":"73","author":"de Andrade Martins","year":"1999","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.hoc.2005.07.007_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ajh.20238","article-title":"Echocardiographic abnormalities in Brazilian sickle cell patients","volume":"78","author":"Vicari","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/02724936.2000.11748143","article-title":"Cardiovascular function in Omani children with sickle cell anaemia","volume":"20","author":"Wali","year":"2000","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.hoc.2005.07.007_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0735-1097(85)80172-8","article-title":"Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound","volume":"6","author":"Berger","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hoc.2005.07.007_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9149(90)90711-9","article-title":"Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava","volume":"66","author":"Kircher","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hoc.2005.07.007_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension: results form a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.93.3.484","article-title":"Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension","volume":"93","author":"Raffy","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hoc.2005.07.007_bib47","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2003-08-2733","article-title":"Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study","volume":"103","author":"Adams","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.007_bib48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V84.2.643.643","article-title":"The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease","volume":"84","author":"Castro","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.007_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease: rates and risk factors","volume":"325","author":"Platt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.0.CO;2-8","article-title":"Renal abnormalities in sickle cell disease","volume":"63","author":"Ataga","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0889-8588(18)30426-X","article-title":"Beta s-gene-cluster haplotypes in sickle cell anemia: clinical and hematologic features","volume":"5","author":"Powars","year":"1991","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1 Suppl 1","key":"10.1016\/j.hoc.2005.07.007_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0037-1963(01)90060-5","article-title":"Progression of iron overload in sickle cell disease","volume":"38","author":"Olivieri","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib53","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0895-4356(92)90073-V","article-title":"Laboratory profile of sickle cell disease: a cross-sectional analysis","volume":"45","author":"West","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hoc.2005.07.007_bib54","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2005.07.007_bib55","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/0091270004273526","article-title":"The influence of renal function on hydroxyurea pharmacokinetics in adults with sickle cell disease","volume":"45","author":"Yan","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.hoc.2005.07.007_bib56","first-page":"817","article-title":"Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure","volume":"7","author":"Tomson","year":"1992","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1, Part 1","key":"10.1016\/j.hoc.2005.07.007_bib57","first-page":"11","article-title":"High dose erythropoietin in sickle cell anemia patients with renal disease","volume":"88","author":"Claster","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.007_bib58","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1067\/mpd.2001.119593","article-title":"Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.hoc.2005.07.007_bib59","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.hoc.2004.06.019","article-title":"Iron chelation therapy in sickle-cell disease and other transfusion-dependent anemias","volume":"18","author":"Kwiatkowski","year":"2004","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1 Suppl 1","key":"10.1016\/j.hoc.2005.07.007_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0037-1963(01)90059-9","article-title":"Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease","volume":"38","author":"Brittenham","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib61","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V89.3.739","article-title":"Iron-chelating therapy and the treatment of thalassemia","volume":"89","author":"Olivieri","year":"1997","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2005.07.007_bib62","first-page":"827","article-title":"A phase II study with ICL670 (Exjade), a once-daily oral iron chelator, in patients with various transfusion-dependent anemias and iron overload","volume":"104","author":"Porter","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.007_bib63","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib64","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5858\/2001-125-1436-PTAIPW","article-title":"Pulmonary thrombotic arteriopathy in patients with sickle cell disease","volume":"125","author":"Adedeji","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib65","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1164\/ajrccm.157.5.9710032","article-title":"Successful pulmonary thromboendarterectomy in two patients with sickle cell disease","volume":"157","author":"Yung","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib66","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"Primary Pulmonary Hypertension Group: a comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib67","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib68","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.RVI.0000121410.46920.6E","article-title":"Infectious complications of implantable venous access devices in patients with sickle cell disease","volume":"15","author":"Wagner","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hoc.2005.07.007_bib69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00005344-200302000-00019","article-title":"Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension","volume":"41","author":"McLaughlin","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hoc.2005.07.007_bib70","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib71","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/rccm.200404-445OC","article-title":"Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"170","author":"Sitbon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hoc.2005.07.007_bib72","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood.V92.7.2594","article-title":"Increased levels of endothelin-1 in plasma of sickle cell anemia patients","volume":"92","author":"Rybicki","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.007_bib73","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2141.2005.05625.x","article-title":"Pulmonary hypertension in sickle cell disease: cardiopulmonary evaluation and response to chronic phosphodiesterase 5 inhibitor therapy","volume":"130","author":"Machado","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2005.07.007_bib74","first-page":"452","article-title":"Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies","volume":"90","author":"Derchi","year":"2005","journal-title":"Haematologica"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858805000882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858805000882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:37:47Z","timestamp":1760182667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858805000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0889858805000882"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2005.07.007","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Hypertension in Sickle Cell Disease: Mechanisms, Diagnosis, and Management","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2005.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}